India to Mexico: Docetaxel Export Trade Route
India has recorded 46 verified shipments of Docetaxel exported to Mexico, representing a combined trade value of $1.7M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $37.4K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 80% of total export value with 6 shipments worth $1.4M USD. On the buying side, ACCORD FARMA S A DE C V is the largest importer in Mexico with $711.1K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Mexico Docetaxel corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $1.7M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $37.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #20 among India's top docetaxel export destinations globally.
On the import side, key buyers of Indian docetaxel in Mexico include ACCORD FARMA S A DE C V, TO THE ORDER, FRESENIUS KABI MEXICO, S.A. DE C.V. and 15 others. ACCORD FARMA S A DE C V is the single largest importer with 2 shipments valued at $711.1K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#20
- Annual growth+25.1%
- Demand growth+23.0%
- Regulatory ease88/100
Top 10 Indian Docetaxel Exporters to Mexico
Showing top 10 of 10 Indian suppliers exporting Docetaxel to Mexico, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $229.3K per shipment | 6 | $1.4M | 79.9% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED Avg $26.2K per shipment | 11 | $288.7K | 16.8% |
| 3 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $23.0K per shipment | 1 | $23.0K | 1.3% |
| 4 | MEDINEX HEALTHCARE Avg $796 per shipment | 16 | $12.7K | 0.7% |
| 5 | FRESENIUS KABI ONCOLOGY LIMITED Avg $10.6K per shipment | 1 | $10.6K | 0.6% |
| 6 | ATLAS ENTERPRISES Avg $1.5K per shipment | 3 | $4.4K | 0.3% |
| 7 | MEDINEX HEALTHCARE Avg $925 per shipment | 3 | $2.8K | 0.2% |
| 8 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $792 per shipment | 3 | $2.4K | 0.1% |
| 9 | TRIKAYA GLOBAL Avg $1.6K per shipment | 1 | $1.6K | 0.1% |
| 10 | VAMA LIFECARE PRIVATE LIMITED Avg $41 per shipment | 1 | $41 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting docetaxel to Mexico, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, MEDINEX HEALTHCARE, FRESENIUS KABI ONCOLOGY LIMITED , ATLAS ENTERPRISES, MEDINEX HEALTHCARE , MYGENIC HEALTHCARE PRIVATE LIMITED, TRIKAYA GLOBAL, VAMA LIFECARE PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 6 shipments worth $1.4M USD, giving it a 80% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Docetaxel Importers in Mexico
Showing top 10 of 18 known buyers in Mexico receiving Docetaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian docetaxel in Mexico include ACCORD FARMA S A DE C V, TO THE ORDER, FRESENIUS KABI MEXICO, S.A. DE C.V., ACCORD FARMA S.A. DE C.V., FRESENIUS KABI MEXICO S.A. DE C.V., among 18 total buyers. The largest importer is ACCORD FARMA S A DE C V, accounting for $711.1K USD across 2 shipments — representing 41% of all docetaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD FARMA S A DE C V | 2 | $711.1K | 41.3% |
| 2 | TO THE ORDER | 3 | $589.0K | 34.2% |
| 3 | FRESENIUS KABI MEXICO, S.A. DE C.V. | 6 | $162.3K | 9.4% |
| 4 | ACCORD FARMA S.A. DE C.V. | 1 | $76.0K | 4.4% |
| 5 | FRESENIUS KABI MEXICO S.A. DE C.V. | 2 | $51.8K | 3.0% |
| 6 | FRESENIUS KABI MEXICO SA DE | 2 | $47.0K | 2.7% |
| 7 | FRESENIUS KABI MEXICO S A DE C V | 1 | $27.6K | 1.6% |
| 8 | GABAME WH | 1 | $23.0K | 1.3% |
| 9 | FRESENIUS KABI MEXICO S.A. DE C.V., | 1 | $10.6K | 0.6% |
| 10 | TO THE ORDER OF, | 14 | $10.6K | 0.6% |
Showing top 10 of 18 Docetaxel importers in Mexico on this route.
Top 10 Docetaxel Formulations Imported by Mexico
Showing top 10 of 39 product formulations shipped on the India to Mexico Docetaxel route, ranked by trade value
Mexico imports a wide range of docetaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS AND MEDI TAXANIT RTU 4 ML 20 MG/ML 4ML TAXANIT RTU 4 ML INJECTION EACH ML CONTAINS: DOCETAXEL ANHYDROUS — accounts for $711.1K USD across 2 shipments. There are 39 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS AND MEDI TAXANIT RTU 4 ML 20 MG/ML 4ML TAXANIT RTU 4 ML INJECTION EACH ML CONTAINS: DOCETAXEL ANHYDROUS | 2 | $711.1K | 41.3% |
| 2 | PHARMA DRUG&MED: TAXANIT RTU 4 ML (20 mg/ml, 4ml) TAXANIT RTU 4 ML INJECTION EACH ML CONTAINS: DOCETAXEL ANHYDROUS PH.EU | 3 | $589.0K | 34.2% |
| 3 | PHARMA. DRUGS & MEDICINE TAXANIT RTU 1ML (20MG/ML1 ML) TAXANIT RTU 1 ML INJ.EACH ML CONT.: DOCETAXEL | 1 | $76.0K | 4.4% |
| 4 | DAXEL (DOCETAXEL) INJ. 80MG/4ML VIAL BATCH NO. 87240161BD, MFG. DT. 01/05/2024,EXP. DT. 30/04/2026 | 1 | $50.8K | 2.9% |
| 5 | DAXEL (DOCETAXEL)INJ.80MG/4ML VIAL B/N:87240002BF MFG:02/01/2024 EXP:31/12/2025NOS | 1 | $32.1K | 1.9% |
| 6 | DAXEL DOCETAXEL INJ. 80MG/4ML VIAL B/N:87230402BD MANUFACTURING :29/08/2023 EXP:31/07/2025 | 1 | $31.7K | 1.8% |
| 7 | DAXEL (DOCETAXEL) INJ. 80MG/4ML VIAL BAT | 1 | $31.7K | 1.8% |
| 8 | DAXEL (DOCETAXEL) INJ. 80MG/4ML VIAL BAT | 1 | $31.4K | 1.8% |
| 9 | DAXEL DOCETAXEL INJ 80MG 4ML VIAL BATCH NO 87250103AI MFG DT 03 2025 EXP DT 02 2027 800 VIALS | 1 | $27.6K | 1.6% |
| 10 | DOCETAXEL INJECTION USP CONCENTRATE 20MG/0.5ML (DOCETAXEL INJECTION USP CONCENTRATE 20MG/0.5ML)(7671 VIALS) | 1 | $23.0K | 1.3% |
Showing top 10 of 39 Docetaxel formulations imported by Mexico on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 18 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's docetaxel exports to Mexico are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $37.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drug&med: taxanit rtu 4 ml (20 mg/ml, 4ml) taxanit rtu 4 ml injection each ml contains: docetaxel anhydrous ph.eu and pharma. drugs & medicine taxanit rtu 1ml (20mg/ml1 ml) taxanit rtu 1 ml inj.each ml cont.: docetaxel, suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD FARMA S A DE C V is the largest importer with 2 shipments worth $711.1K USD — representing 41% of all docetaxel imports from India on this route. A total of 18 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.7M
- Avg. Shipment
- $37.4K
- Suppliers
- 10
- Buyers
- 18
- Transit (Sea)
- ~29 days
- Annual Growth
- +25.1%
Other Docetaxel Routes
Unlock the Full India to Mexico Docetaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 46 shipments on this route.
Frequently Asked Questions — India to Mexico Docetaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Docetaxel to Mexico?
The leading Indian exporters of Docetaxel to Mexico are INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 80% of total trade value on this route.
Q What is the total value of Docetaxel exports from India to Mexico?
India exports Docetaxel to Mexico worth approximately $1.7M USD across 46 recorded shipments. The average value per shipment is $37.4K USD.
Q Which ports does India use to ship Docetaxel to Mexico?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 18 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Mexico for Docetaxel?
The average transit time for Docetaxel shipments from India to Mexico is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Mexico Docetaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.1% with demand growth tracking at 23.0%. The route is ranked #20 among India's top Docetaxel export destinations globally.
Q How many suppliers are active on the India to Mexico Docetaxel route?
There are currently 10 active Indian suppliers exporting Docetaxel to Mexico. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 80% of total shipment value.
Q Who are the main importers of Docetaxel from India in Mexico?
The leading importers of Indian Docetaxel in Mexico include ACCORD FARMA S A DE C V, TO THE ORDER, FRESENIUS KABI MEXICO, S.A. DE C.V., ACCORD FARMA S.A. DE C.V., FRESENIUS KABI MEXICO S.A. DE C.V.. ACCORD FARMA S A DE C V is the largest buyer with 2 shipments worth $711.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Mexico export trade corridor identified from Indian Customs (DGFT) records for Docetaxel.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 18 importers in Mexico matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 46 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
46 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists